Tissue inhibitor of matrix metalloproteinase 1 (TIMP1) controls adipogenesis in obesity in mice and in humans.
暂无分享,去创建一个
[1] K. Flegal,et al. Prevalence and trends in obesity among US adults, 1999-2008. , 2010, JAMA.
[2] Y. Even,et al. Depot‐Specific Differences in Adipogenic Progenitor Abundance and Proliferative Response to High‐Fat Diet , 2009, Stem cells.
[3] T. Stulnig,et al. Obesity, Inflammation, and Insulin Resistance – A Mini-Review , 2009, Gerontology.
[4] I. Gérin,et al. Hyperphagia and obesity in female mice lacking tissue inhibitor of metalloproteinase-1. , 2009, Endocrinology.
[5] Junghyo Jo,et al. Hypertrophy and/or Hyperplasia: Dynamics of Adipose Tissue Growth , 2009, PLoS Comput. Biol..
[6] H. Lijnen,et al. A functional role of gelatinase A in the development of nutritionally induced obesity in mice , 2008, Journal of thrombosis and haemostasis : JTH.
[7] M. Fasshauer,et al. Tissue inhibitor of metalloproteinase-1 mRNA production and protein secretion are induced by interleukin-1 beta in 3T3-L1 adipocytes. , 2008, The Journal of endocrinology.
[8] C. Apovian,et al. Obesity prevalence from a European perspective: a systematic review , 2008, BMC public health.
[9] Tom Britton,et al. Dynamics of fat cell turnover in humans , 2008, Nature.
[10] G. Goossens. The role of adipose tissue dysfunction in the pathogenesis of obesity-related insulin resistance , 2008, Physiology & Behavior.
[11] C. Kahn,et al. Developmental Origin of Fat: Tracking Obesity to Its Source , 2007, Cell.
[12] E. Maury,et al. Adipokines oversecreted by omental adipose tissue in human obesity. , 2007, American journal of physiology. Endocrinology and metabolism.
[13] N. Viguerie,et al. Profiling of adipokines secreted from human subcutaneous adipose tissue in response to PPAR agonists. , 2007, Biochemical and biophysical research communications.
[14] A. Vidal-Puig,et al. Thematic review series: Adipocyte Biology. Adipose tissue function and plasticity orchestrate nutritional adaptation Published, JLR Papers in Press, March 20, 2007. , 2007, Journal of Lipid Research.
[15] R. Paschke,et al. Tissue inhibitor of metalloproteinase-1 predicts adiposity in humans. , 2007, European journal of endocrinology.
[16] Parvez Hossain,et al. Obesity and diabetes in the developing world--a growing challenge. , 2007, The New England journal of medicine.
[17] F. Renström,et al. Fat cell enlargement is an independent marker of insulin resistance and ‘hyperleptinaemia’ , 2007, Diabetologia.
[18] S. Kersten,et al. PPARs, Obesity, and Inflammation , 2006, PPAR research.
[19] Anne E Carpenter,et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes , 2006, Genome Biology.
[20] I. Scroyen,et al. Overexpression of tissue inhibitor of matrix metalloproteinases-1 (TIMP-1) in mice does not affect adipogenesis or adipose tissue development , 2006, Thrombosis and Haemostasis.
[21] A. Gansmuller,et al. Stromelysin-3 is a potent negative regulator of adipogenesis participating to cancer cell-adipocyte interaction/crosstalk at the tumor invasive front. , 2005, Cancer research.
[22] R. Paschke,et al. Proinflammatory adipocytokines induce TIMP‐1 expression in 3T3‐L1 adipocytes , 2005, FEBS letters.
[23] V. Bourlier,et al. Protease Inhibitor Treatments Reveal Specific Involvement of Matrix Metalloproteinase-9 in Human Adipocyte Differentiation , 2005, Journal of Pharmacology and Experimental Therapeutics.
[24] P. A. Tataranni,et al. Subcutaneous abdominal preadipocyte differentiation in vitro inversely correlates with central obesity. , 2004, American journal of physiology. Endocrinology and metabolism.
[25] A. Noël,et al. Diet-Induced Obesity and Reduced Skin Cancer Susceptibility in Matrix Metalloproteinase 19-Deficient Mice , 2004, Molecular and Cellular Biology.
[26] Christian Wolfrum,et al. Role of Foxa-2 in adipocyte metabolism and differentiation. , 2003, The Journal of clinical investigation.
[27] E. Van Obberghen,et al. Matrix Metalloproteinases Are Differentially Expressed in Adipose Tissue during Obesity and Modulate Adipocyte Differentiation* , 2003, The Journal of Biological Chemistry.
[28] H. Lijnen,et al. Enhanced nutritionally induced adipose tissue development in mice with stromelysin-1 gene inactivation , 2003, Thrombosis and Haemostasis.
[29] F. Renström,et al. In vitro reversal of hyperglycemia normalizes insulin action in fat cells from type 2 diabetes patients: is cellular insulin resistance caused by glucotoxicity in vivo? , 2003, Metabolism: clinical and experimental.
[30] D. Collen,et al. Deficiency of tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) impairs nutritionally induced obesity in mice , 2003, Thrombosis and Haemostasis.
[31] Hubert C Chen,et al. Determination of adipocyte size by computer image analysis. , 2002, Journal of lipid research.
[32] Z. Werb,et al. Metalloproteases and adipogenesis: a weighty subject. , 2002, The American journal of pathology.
[33] Carine Munaut,et al. Modulation of adipose tissue expression of murine matrix metalloproteinases and their tissue inhibitors with obesity. , 2002, Diabetes.
[34] H. Lijnen,et al. Matrix Metalloproteinase Inhibition Impairs Adipose Tissue Development in Mice , 2002, Arteriosclerosis, thrombosis, and vascular biology.
[35] H. Lijnen,et al. Adipocyte Hypertrophy in Stromelysin-3 Deficient Mice with Nutritionally Induced Obesity , 2002, Thrombosis and Haemostasis.
[36] F. Gregoire. Adipocyte Differentiation: From Fibroblast to Endocrine Cell , 2001, Experimental biology and medicine.
[37] M. Lafontan,et al. Adipocyte produces matrix metalloproteinases 2 and 9: involvement in adipose differentiation. , 2001, Diabetes.
[38] C. Craik,et al. A plasma kallikrein-dependent plasminogen cascade required for adipocyte differentiation , 2001, Nature Cell Biology.
[39] Z. Werb,et al. Stromelysin-1 Regulates Adipogenesis during Mammary Gland Involution , 2001, The Journal of cell biology.
[40] B. Wajchenberg. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. , 2000, Endocrine reviews.
[41] C. Bogardus,et al. Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts Type II diabetes independent of insulin resistance , 2000, Diabetologia.
[42] C. Kahn,et al. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance , 2000, Nature Medicine.
[43] J. Nielsen,et al. Characterization of the inhibitory effect of growth hormone on primary preadipocyte differentiation. , 1998, Molecular endocrinology.
[44] N. Bersch,et al. Metalloproteinase inhibition and erythroid potentiation are independent activities of tissue inhibitor of metalloproteinases-1. , 1995, Blood.
[45] F. Weiner,et al. Regulation of collagen gene expression in 3T3-L1 cells. Effects of adipocyte differentiation and tumor necrosis factor alpha. , 1989, Biochemistry.
[46] Y. Aratani,et al. Enhanced synthesis and secretion of type IV collagen and entactin during adipose conversion of 3T3-L1 cells and production of unorthodox laminin complex. , 1988, The Journal of biological chemistry.
[47] B. Spiegelman,et al. Fibronectin modulation of cell shape and lipogenic gene expression in 3t3-adipocytes , 1983, Cell.
[48] J. Dougherty,et al. The effect of insulin upon glucose metabolism by adipose cells of different size. Influence of cell lipid and protein content, age, and nutritional state. , 1971, The Journal of clinical investigation.
[49] K. Brew,et al. The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. , 2010, Biochimica et biophysica acta.
[50] G. Holz. Epac: A new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell. , 2004, Diabetes.
[51] K. Steinberg,et al. Increased Angiostatin Levels in Bronchoalveolar Lavage Fluids from ARDS Patients and from Human Volunteers after Lung Instillation of Endotoxin , 2002, Thrombosis and Haemostasis.
[52] K. Takenouchi,et al. Organization of extracellular matrix components during differentiation of adipocytes in long-term culture , 2000, In Vitro Cellular & Developmental Biology - Animal.